Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,883,850
-
Share change
-
+1,989,795
-
Total reported value
-
$278,777,860
-
Put/Call ratio
-
36%
-
Price per share
-
$10.00
-
Number of holders
-
96
-
Value change
-
+$21,813,158
-
Number of buys
-
54
-
Number of sells
-
27
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q3 2018
As of 30 Sep 2018,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,883,850 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, BlackRock Inc., THREE BAYS CAPITAL LP, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, Partner Fund Management, L.P., Vanguard Group Inc, 683 Capital Management, LLC, Granite Point Capital Management, L.P., and CREDIT SUISSE AG/.
This page lists
96
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.